BIOMAT Database Logo BIOMAT Database Logo

Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge. 2013

S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Foot-and-Mouth Disease Vaccine Centre, Indian Veterinary Research Institute, Hebbal, Bangalore 560 024, Karnataka, India.

Vaccination is a well accepted strategy for control of foot-and-mouth disease (FMD) in endemic countries. Currently, chemically inactivated virus antigens are used for preparation of FMD vaccine. To develop a non-infectious and safe recombinant vaccine, we expressed structural polypeptide of FMDV (O/IND/R2/75) using baculovirus expression system. We show that inclusion of mutated viral 3C protease in frame with the polypeptide (P1-2A), enhanced the yield of structural proteins. The structural proteins retained antigenicity and assembled into empty virus-like particles (VLPs). Immunization of guinea pigs with purified fractions of the VLPs resulted in humoral and cell mediated immune response by 4 weeks. The VLPs elicited comparable humoral immune response and relatively higher cell mediated immune response, when compared to conventional vaccine in guinea pigs. Further, up to 70% of the VLP immunized guinea pigs were protected against challenge with homologous guinea pig adapted virus. Our results highlight the application of recombinant FMDV VLPs in FMD vaccination.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005536 Foot-and-Mouth Disease A highly infectious disease caused by FOOT AND MOUTH DISEASE VIRUS that affects mammals of the ARTIODACTYLA order (CATTLE; SHEEP; GOATS; and PIGS) and is characterized by high fever followed by the appearance of blisters inside the mouth and on the feet. Foot and Mouth Disease,Disease, Foot-and-Mouth,Diseases, Foot-and-Mouth,Foot-and-Mouth Diseases
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic

Related Publications

S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
February 2016, Veterinary microbiology,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Adenovirus-Vectored Capsid Proteins of the Serotype A Foot-and-Mouth Disease Virus Protect Guinea Pigs Against Challenge.
January 2020, Frontiers in microbiology,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
June 2017, Applied microbiology and biotechnology,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
January 2018, Virus research,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
[Immunity and immunization against foot-and-mouth disease (FMD) virus].
August 1972, Berliner und Munchener tierarztliche Wochenschrift,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
May 2005, Archives of virology,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
September 2004, Vaccine,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
FMD. (Foot and Mouth Disease)
March 1947, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
January 1972, Archiv fur die gesamte Virusforschung,
S A Bhat, and P Saravanan, and M Hosamani, and S H Basagoudanavar, and B P Sreenivasa, and R P Tamilselvan, and R Venkataramanan
Deciphering foot-and-mouth disease (FMD) virus-host tropism.
November 2019, Journal of biomolecular structure & dynamics,
Copied contents to your clipboard!